Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.

The Clinical Trials Research Pillar in the Division of Biostatistics is at the forefront of innovative clinical trial design ...

The primary value of placebo controls in clinical trials is the minimization of bias.

The evolution of the safety and effectiveness evaluation of endovascular grafts intended for abdominal aortic aneurysm repair ...

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical trials for glioblastoma, a type of brain tumor. Recently, the items have ...

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

Lant Medical has secured £500,000 investment from Innovate UK, the UK's innovation agency, and two angel investors from the ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

Q4 2024 Management View CEO Jim Brown emphasized the company’s focus on advancing larsucosterol, their lead asset for treating alcohol-associated hepatitis (AH). He highlighted the significant unmet ...

IMUNON (IMNN) announced that the U.S. Food and Drug Administration is aligned with the protocol for the Phase 3 pivotal trial, called OVATION ...

Phase III DIPPER trial shows that adjuvant camrelizumab administered after induction-concurrent chemoradiotherapy ...